The Vivienne's sister questions if drug use ‘stigma' stopped them seeking help
The Vivienne's sister questions if drug use 'stigma' stopped them seeking help
The Drag Race star died at home earlier this year
The sister of The Vivienne has questioned whether the 'stigma' around drug use stopped the drag queen from seeking help
(Image: PA Wire/PA Images )
The sister of The Vivienne has questioned whether the "stigma" around drug use stopped the drag queen from seeking help.
James Lee Williams, who won the first series of RuPaul's Drag Race UK, died at home in Chorlton-by-Backford, Cheshire, on January 5 after taking ketamine at the age of 32.
Chanel Williams told BBC Two current affairs programme Newsnight that The Vivienne did not discuss their relapse, including a hospital stay, "to protect them", following "a really long period of sobriety".
"It's hard for me because I think, if that stigma wasn't there, would my brother have sought the help he needed?" she said.
"To think that, if we'd known, or if he'd have felt able to talk and really reach out for the help that was needed, the outcome could've been different.
Article continues below
"That's why we've shared James's story."
The family revealed in March that the drag queen died "from the effects of ketamine use causing a cardiac arrest", to raise awareness.
They also said they would work with the drug charity Adferiad on future campaigns.
"He'd spoken openly on Drag Race about the battles he'd had with addiction, and he'd come through the other side of that," Ms Williams said.
"He was at the height of everything he was doing and I think, because he'd said it in such an open platform, it's really difficult to come back and say you're struggling again."
She also said the classification of ketamine should be moved from Class B to Class A, because people "think it's less harmful than other drugs", among other measures to tackle addiction.
She added: "But it's not just about reclassification... it needs to include education, police, health, to really raise awareness. We need a strategy around drug usage and drug deaths in the UK."
The Government is seeking expert advice after the illegal use of ketamine surged to record levels.
While on the BBC show, Wales-born The Vivienne admitted having been a drug addict for four years, saying the addiction was a "habit that caught on a bit too quick and a bit too hard".
Reflecting on sobriety, the musical theatre and Dancing On Ice star said: "I had to be kicked out of my house and told that I would be dead by the time I was 30.
"It was the loneliest part of my life. I was killing myself... and my family don't even know. I was pissing my life up the wall and I could've been dead now if I didn't do anything about it."
An inquest into their death was opened and adjourned at Cheshire Coroner's Court in Warrington, with a full inquest listed to take place on June 30.
According to the Home Office, in the year ending March 2023 an estimated 299,000 people aged 16 to 59 had reported use of ketamine, which is controlled as Class B.
The UK national anti-drug advisory service Frank says the substance is a general anaesthetic that reduces sensations in the body which can make users feel dream-like and detached, chilled, relaxed and happy, but also confused and nauseated.
Policing minister Dame Diana Johnson wrote to the Advisory Council on the Misuse of Drugs (ACMD) in January to express the Government's concern over young people's ketamine use and call for the classification to be reassessed.
Article continues below
A Home Office spokesman said: "Our thoughts are with James's family and friends, and all those affected by this tragic death, which has sadly reinforced once again the serious dangers of taking ketamine.
"In January this year, the minister for policing and crime prevention wrote to the Advisory Council on the Misuse of Drugs expressing the Government's concern about the growth in the use of ketamine, and asking them to consider whether to reclassify it as a Class A drug.
"We will not hesitate to act when the ACMD reports back, and, in the meantime, we will continue to work across health, policing and wider public services to drive down drug use and stop those who profit from its supply."
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Daily Mail
2 hours ago
- Daily Mail
Top scientists flag little-known earliest signs of dementia that have nothing to do with memory
Changes in sight, hearing, taste, touch and balance are little-known dementia signs that can strike years before more well-known symptoms, experts have warned. Dementia, a condition which blights the lives of millions, famously causes problems with patients' memory, language and mood. Medics, using tools like memory tests and interviews, assess these when diagnosing the condition. But now scientists say there is substantial evidence that dementia starts to impair the senses many years before a patient shows the classic signs. This they say, offers hope that sensory changes can be used as an early warning sign and help patients be diagnosed far sooner. They have now called for such changes to be included in standard dementia diagnostic tests which have predominantly focused on recording memory difficulties. An early diagnosis for dementia is considered critical as, while the condition is incurable, treatments can combat symptoms and sometimes slow progression. The team includes three dementia experts in Professor Andrea Tales, of Swansea University, Dr Emma Richards of Public Health Wales and Professor Jan Kremláček of Charles University in Prague. 'Broadening the diagnostic approach beyond memory testing raised the potential to identify dementia at preclinical stages when therapies and life modifications may be most effective,' Professor Kremláček explained. Dr Richards added: 'Many patients report experiencing these sensory changes years before receiving a diagnosis, but these symptoms may be overlooked during standard cognitive assessments. 'Understanding and addressing these issues, and providing support earlier could be transformative, enabling health care providers to offer the vital emotional and social support patients need at a potentially confusing and distressing time. 'In addition to this, understanding changes in a person's senses can help support a clinician in determining a dementia diagnosis.' Dementia, and particularly early signs of the condition, has been linked to changes in sensory perception before. As the condition is neurodegenerative, meaning it causes continuous brain atrophy, loss of brain tissue and volume, over time, this is believed to have an impact on how our senses function, even in the early stages. Earlier this year neurologists highlighted that a loss of sense of smell could be an early sign of dementia and strike 10-years before better-known symptoms. It isn't just smell—vision disturbances and problems with balance are some of the earliest, but often dismissed, signs, especially in younger patients. Writing for The Conversation earlier this year, Molly Murray, an expert in young-onset dementia from the University of West Scotland, said for many patients the first sign of the condition is a problem with their eyes. 'Research shows that for around one third of people with young-onset Alzheimer's disease [the most common form of dementia] , the earliest symptoms they had were problems with coordination and vision changes,' she wrote. Experts have also warned that problems with spatial awareness such as standing too close to people are also potential dementia warning signs which can occur up to twenty years before the classic symptoms. More than 944,000 people in the UK are thought to be living with dementia, while the figure is thought to be around seven million in the US. Recent analysis by the Alzheimer's Society estimated the overall annual cost of the dementia to the UK is £42billion a year, with families bearing the brunt. An ageing population means these costs—which include lost earnings of unpaid carers—are set to soar to £90billion in the next 15 years. A separate Alzheimer's Research UK analysis found 74,261 people died from dementia in 2022 compared with 69,178 a year earlier, making it the country's biggest killer.
The Independent
6 hours ago
- The Independent
New NHS guidelines mean younger women could have fewer cervical screenings
Women aged 25 to 49 who test negative for human papillomavirus (HPV) will be invited to cervical screening every five years instead of every three, under new NHS guidelines. The change, set to take effect next month in England, follows recommendations from the UK National Screening Committee. According to analysis from King's College London, extending the screening interval to five years for HPV-negative women is just as safe as the current three-year interval, with a similar rate of cancer detection. HPV is a sexually transmitted group of viruses, with around 13 high-risk types known to cause almost all cases of cervical cancer. Most people with HPV don't experience any symptoms. Women who test positive for HPV, or have a history of the virus, will continue to be invited for more frequent screenings to monitor the virus and check for any changes to cells in the cervix. In a written statement to Parliament, health minister Ashley Dalton said the new change 'increases the opportunities to test and recall women and people with a cervix who have HPV, while extending the cervical screening intervals from three to five years in England for individuals who have a negative HPV test. 'This will bring England's cervical screening intervals in line with those of Wales and Scotland.' She said the NHS screening programme in England provides all women between the ages of 25 and 64 'with the opportunity to be screened routinely to detect HPV infection or cervical abnormalities at an early, more treatable stage'. She added: 'The aim of the programme is to reduce the number of women who develop invasive cervical cancer and reduce the number who die from it.' Ms Dalton said testing negative for HPV means the chances of developing cancer within five years are very small, as it can take around 10 years or more from the time HPV is detected to developing cervical cancer. She added: 'Those who test positive for HPV are already being followed up with yearly testing. 'This is important to ensure that individuals are monitored for any early signs of cervical abnormalities and provided the necessary treatment.' Experts have been concerned about falling numbers of women under 50 attending cervical screening, with around a third in England not taking up their invitations. Dr Sue Mann, NHS national clinical director for women's health, said: 'Taking a more personalised approach to cervical screening will help ensure everyone eligible can make the most of these life-saving services, while sparing women appointments that they don't need. 'The NHS is following robust evidence on how often women need to be safely screened, and by putting invitations and reminders straight in women's pockets on their phones, we're making it easier than ever to take up screening appointments. 'Make sure you come forward for your screening when you're invited, even if it was weeks, months or years ago. If you think you are due but have not yet had an invitation, speak to your GP practice.' Michelle Mitchell, chief executive of Cancer Research UK, said: 'We welcome this change to cervical screening in England, which is the result of years of vital research to make screening more effective and has shown it is safe to extend the time between tests. 'Screening, alongside the roll out of the HPV vaccine – which Cancer Research UK scientists helped develop – have seen cervical cancer rates drop by around a quarter since the early 1990s, and we look forward to even more progress. 'If you notice any unusual changes for you, do not wait for a screening invitation – speak to your doctor.' Athena Lamnisos, chief executive of the Eve Appeal, said: 'We want every eligible person to feel empowered to attend a vaccination and cervical screening appointment when they are invited so we can achieve the brilliant ambition of eliminating cervical cancer.'
The Independent
8 hours ago
- The Independent
NHS updates cervical screening guidelines with millions of women affected
Women aged 25 to 49 who test negative for human papillomavirus (HPV) will be invited to cervical screening every five years instead of every three, under new NHS guidelines. The change, set to take effect next month in England, follows recommendations from the UK National Screening Committee. According to analysis from King's College London, extending the screening interval to five years for HPV-negative women is just as safe as the current three-year interval, with a similar rate of cancer detection. HPV is a sexually transmitted group of viruses, with around 13 high-risk types known to cause almost all cases of cervical cancer. Most people with HPV don't experience any symptoms. Women who test positive for HPV, or have a history of the virus, will continue to be invited for more frequent screenings to monitor the virus and check for any changes to cells in the cervix. In a written statement to Parliament, health minister Ashley Dalton said the new change 'increases the opportunities to test and recall women and people with a cervix who have HPV, while extending the cervical screening intervals from three to five years in England for individuals who have a negative HPV test. 'This will bring England's cervical screening intervals in line with those of Wales and Scotland.' She said the NHS screening programme in England provides all women between the ages of 25 and 64 'with the opportunity to be screened routinely to detect HPV infection or cervical abnormalities at an early, more treatable stage'. She added: 'The aim of the programme is to reduce the number of women who develop invasive cervical cancer and reduce the number who die from it.' Ms Dalton said testing negative for HPV means the chances of developing cancer within five years are very small, as it can take around 10 years or more from the time HPV is detected to developing cervical cancer. She added: 'Those who test positive for HPV are already being followed up with yearly testing. 'This is important to ensure that individuals are monitored for any early signs of cervical abnormalities and provided the necessary treatment.' Experts have been concerned about falling numbers of women under 50 attending cervical screening, with around a third in England not taking up their invitations. Dr Sue Mann, NHS national clinical director for women's health, said: 'Taking a more personalised approach to cervical screening will help ensure everyone eligible can make the most of these life-saving services, while sparing women appointments that they don't need. 'The NHS is following robust evidence on how often women need to be safely screened, and by putting invitations and reminders straight in women's pockets on their phones, we're making it easier than ever to take up screening appointments. 'Make sure you come forward for your screening when you're invited, even if it was weeks, months or years ago. If you think you are due but have not yet had an invitation, speak to your GP practice.' Michelle Mitchell, chief executive of Cancer Research UK, said: 'We welcome this change to cervical screening in England, which is the result of years of vital research to make screening more effective and has shown it is safe to extend the time between tests. 'Screening, alongside the roll out of the HPV vaccine – which Cancer Research UK scientists helped develop – have seen cervical cancer rates drop by around a quarter since the early 1990s, and we look forward to even more progress. 'If you notice any unusual changes for you, do not wait for a screening invitation – speak to your doctor.' Athena Lamnisos, chief executive of the Eve Appeal, said: 'We want every eligible person to feel empowered to attend a vaccination and cervical screening appointment when they are invited so we can achieve the brilliant ambition of eliminating cervical cancer.'
